Dutch biotech Pharming expects to have full access to funds at SVB
13/03/2023 07:43
AMSTERDAM, March 13 (Reuters) - Dutch biotech firm
Pharming PHAR.AS said on Monday it expected to have full
access to its cash on deposit at Silicon Valley Bank, following
the U.S. government's move to insure all depositors at the
collapsed lender.
Pharming on Sunday said it held $45 million in Silicon
Valley Bank's SIVB.O U.S. and British units.
(Reporting by Bart Meijer; editing by Jason Neely)
((Bart.Meijer@thomsonreuters.com;))